Real-World Evidence · Compare
TrialMind vs Aetion Evidence Platform vs IQVIA Analytics Research Accelerator
Real-world evidence platforms, side by side. Pick any product to compare.
| TrialMindKeiji AIAI agents for RWE studies | Datavant (Aetion)Causal-inference RWE analytics platform | IQVIAReal-world data platform | |
|---|---|---|---|
| Best for | Plain-language studies on data you already license, with reviewable code | Templated causal-inference studies with access to Datavant's data partners | Buying or landscaping data across many countries |
| Data | |||
| Data source | Claims, EHR, registry and genomic data you license | 300+ Datavant and Aetion data partners1 | 3,700+ IQVIA data assets, 100+ countries2 |
| Runs on data you already license | Yes: OMOP or your own schemas | Yes: Data-agnostic and modular3 | Yes: Onboard your own sources2 |
| Where data stays | Your environment; raw records not moved | SaaS on AWS3 | Snowflake, AWS S3 or safe rooms2 |
| Analysis | |||
| Plain-language cohorts | Yes: Describe the study, review the plan | Not stated publicly3 | Partly: AI cohort builder suggests concepts2 |
| Audit trail and code | Yes: Attrition table plus SQL, Python or R | Partly: Coding workbench, plain-text audit trails3 | Not stated publicly: Analytic-ready, patient-level datasets2 |
| Fit | |||
| Regulatory use, as the vendor states it | Audit trail; GxP-qualified Data Science Assistant | Built to FDA and EMA standards3 | Not stated publicly2 |
| Academic licensing | Yes: Group, department or institution licenses | Not stated publicly: Biopharma, devices, payers, regulators1 | Not stated publicly2 |
From each company’s public pages, checked 2026-10-21. A dash means the company does not say.
More comparisons
See TrialMind on your own question
A 30-minute walkthrough on a study like yours, with sources and code you can check.
Sources · checked 2026-10-21
Product details come from each company’s public pages. Spotted something out of date? Tell us and we will correct it.